Literature DB >> 20578128

Hepatocyte NAD(P)H oxidases as an endogenous source of reactive oxygen species during hepatitis C virus infection.

Nabora Soledad Reyes de Mochel1, Scott Seronello, Shelley Hsiuying Wang, Chieri Ito, Jasper Xi Zheng, T Jake Liang, J David Lambeth, Jinah Choi.   

Abstract

UNLABELLED: Oxidative stress has been identified as a key mechanism of hepatitis C virus (HCV)-induced pathogenesis. Studies have suggested that HCV increases the generation of hydroxyl radical and peroxynitrite close to the cell nucleus, inflicting DNA damage, but the source of reactive oxygen species (ROS) remains incompletely characterized. We hypothesized that HCV increases the generation of superoxide and hydrogen peroxide close to the hepatocyte nucleus and that this source of ROS is reduced nicotinamide adenine dinucleotide phosphate (NAD(P)H) oxidase 4 (Nox4). Huh7 human hepatoma cells and telomerase-reconstituted primary human hepatocytes, transfected or infected with virus-producing HCV strains of genotypes 2a and 1b, were examined for messenger RNA (mRNA), protein, and subcellular localization of Nox proteins along with the human liver. We found that genotype 2a HCV induced persistent elevations of Nox1 and Nox4 mRNA and proteins in Huh7 cells. HCV genotype 1b likewise elevated the levels of Nox1 and Nox4 in telomerase-reconstituted primary human hepatocytes. Furthermore, Nox1 and Nox4 proteins were increased in HCV-infected human liver versus uninfected liver samples. Unlike Nox1, Nox4 was prominent in the nuclear compartment of these cells as well as the human liver, particularly in the presence of HCV. HCV-induced ROS and nuclear nitrotyrosine could be decreased with small interfering RNAs to Nox1 and Nox4. Finally, HCV increased the level of transforming growth factor beta 1 (TGFbeta1). TGFbeta1 could elevate Nox4 expression in the presence of infectious HCV, and HCV increased Nox4 at least in part through TGFbeta1.
CONCLUSION: HCV induced a persistent elevation of Nox1 and Nox4 and increased nuclear localization of Nox4 in hepatocytes in vitro and in the human liver. Hepatocyte Nox proteins are likely to act as a persistent, endogenous source of ROS during HCV-induced pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20578128      PMCID: PMC3141587          DOI: 10.1002/hep.23671

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  21 in total

1.  Intrahepatic accumulation of nitrotyrosine in chronic viral hepatitis is associated with histological severity of liver disease.

Authors:  C García-Monzón; P L Majano; I Zubia; P Sanz; A Apolinario; R Moreno-Otero
Journal:  J Hepatol       Date:  2000-02       Impact factor: 25.083

2.  Transforming growth factor-beta 1 in chronic hepatitis C.

Authors:  D R Nelson; R P Gonzalez-Peralta; K Qian; Y Xu; C G Marousis; G L Davis; J Y Lau
Journal:  J Viral Hepat       Date:  1997-01       Impact factor: 3.728

Review 3.  Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly.

Authors:  J S Beckman; W H Koppenol
Journal:  Am J Physiol       Date:  1996-11

4.  Essential role of the NADPH oxidase subunit p47(phox) in endothelial cell superoxide production in response to phorbol ester and tumor necrosis factor-alpha.

Authors:  Jian-Mei Li; Adrian M Mullen; Sheng Yun; Frans Wientjes; Gabi Y Brouns; Adrian J Thrasher; Ajay M Shah
Journal:  Circ Res       Date:  2002-02-08       Impact factor: 17.367

5.  Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein.

Authors:  Michiari Okuda; Kui Li; Michael R Beard; Lori A Showalter; Frank Scholle; Stanley M Lemon; Steven A Weinman
Journal:  Gastroenterology       Date:  2002-02       Impact factor: 22.682

6.  Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells.

Authors:  Lula L Hilenski; Roza E Clempus; Mark T Quinn; J David Lambeth; Kathy K Griendling
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-12-11       Impact factor: 8.311

7.  Telomerase reconstitution immortalizes human fetal hepatocytes without disrupting their differentiation potential.

Authors:  Henning Wege; Hai T Le; Michael S Chui; Li Liu; Jian Wu; Ranjit Giri; Harmeet Malhi; Baljit S Sappal; Vinay Kumaran; Sanjeev Gupta; Mark A Zern
Journal:  Gastroenterology       Date:  2003-02       Impact factor: 22.682

8.  Reactive oxygen species suppress hepatitis C virus RNA replication in human hepatoma cells.

Authors:  Jinah Choi; Ki Jeong Lee; Yanyan Zheng; Ardath K Yamaga; Michael M C Lai; Jing-Hsiung Ou
Journal:  Hepatology       Date:  2004-01       Impact factor: 17.425

9.  Hepatitis C virus (HCV) proteins induce NADPH oxidase 4 expression in a transforming growth factor beta-dependent manner: a new contributor to HCV-induced oxidative stress.

Authors:  Howard E Boudreau; Suzanne U Emerson; Agnieszka Korzeniowska; Meghan A Jendrysik; Thomas L Leto
Journal:  J Virol       Date:  2009-10-07       Impact factor: 5.103

10.  gamma-glutamylcysteine synthetase: mRNA stabilization and independent subunit transcription by 4-hydroxy-2-nonenal.

Authors:  R M Liu; L Gao; J Choi; H J Forman
Journal:  Am J Physiol       Date:  1998-11
View more
  75 in total

Review 1.  Therapeutic potential of NADPH oxidase 1/4 inhibitors.

Authors:  G Teixeira; C Szyndralewiez; S Molango; S Carnesecchi; F Heitz; P Wiesel; J M Wood
Journal:  Br J Pharmacol       Date:  2016-07-14       Impact factor: 8.739

Review 2.  NADPH oxidases: an overview from structure to innate immunity-associated pathologies.

Authors:  Arvind Panday; Malaya K Sahoo; Diana Osorio; Sanjay Batra
Journal:  Cell Mol Immunol       Date:  2014-09-29       Impact factor: 11.530

3.  Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver Fibrosis.

Authors:  Daniel Sepulveda-Crespo; Salvador Resino; Isidoro Martinez
Journal:  Drugs       Date:  2021-01-05       Impact factor: 9.546

4.  The NOX1 isoform of NADPH oxidase is involved in dysfunction of liver sinusoids in nonalcoholic fatty liver disease.

Authors:  Misaki Matsumoto; Jia Zhang; Xueqing Zhang; Junjie Liu; Joy X Jiang; Kanji Yamaguchi; Akiyuki Taruno; Masato Katsuyama; Kazumi Iwata; Masakazu Ibi; Wenhao Cui; Kuniharu Matsuno; Yoshinori Marunaka; Yoshito Itoh; Natalie J Torok; Chihiro Yabe-Nishimura
Journal:  Free Radic Biol Med       Date:  2017-12-20       Impact factor: 7.376

5.  NADPH Oxidases in Chronic Liver Diseases.

Authors:  Joy X Jiang; Natalie J Török
Journal:  Adv Hepatol       Date:  2014-11-30

6.  NADPH Oxidase 1 in Liver Macrophages Promotes Inflammation and Tumor Development in Mice.

Authors:  Shuang Liang; Hsiao-Yen Ma; Zhenyu Zhong; Debanjan Dhar; Xiao Liu; Jun Xu; Yukinori Koyama; Takahiro Nishio; Daniel Karin; Gabriel Karin; Ryan Mccubbin; Cuili Zhang; Ronglin Hu; Guizhi Yang; Li Chen; Souradipta Ganguly; Tian Lan; Michael Karin; Tatiana Kisseleva; David A Brenner
Journal:  Gastroenterology       Date:  2018-11-13       Impact factor: 22.682

7.  Therapeutic targeting of GSK3β enhances the Nrf2 antioxidant response and confers hepatic cytoprotection in hepatitis C.

Authors:  Yongfang Jiang; Hui Bao; Yan Ge; Wei Tang; Du Cheng; Kaizhong Luo; Guozhong Gong; Rujun Gong
Journal:  Gut       Date:  2014-05-08       Impact factor: 23.059

Review 8.  Oxidative stress and hepatic Nox proteins in chronic hepatitis C and hepatocellular carcinoma.

Authors:  Jinah Choi; Nicole L B Corder; Bhargav Koduru; Yiyan Wang
Journal:  Free Radic Biol Med       Date:  2014-05-06       Impact factor: 7.376

Review 9.  Role of NADPH oxidases in liver fibrosis.

Authors:  Yong-Han Paik; Jonghwa Kim; Tomonori Aoyama; Samuele De Minicis; Ramon Bataller; David A Brenner
Journal:  Antioxid Redox Signal       Date:  2014-01-24       Impact factor: 8.401

Review 10.  Hepatitis D and hepatocellular carcinoma.

Authors:  Zaigham Abbas; Minaam Abbas; Sarim Abbas; Lubna Shazi
Journal:  World J Hepatol       Date:  2015-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.